Streetbeat News

Earnings

INTC

Intel's Q2 results exceeded expectations and the company issued strong guidance. This led to multiple firms raising their price targets on Intel's stock, resulting in a rise in Intel's share price.

Portfolio Pulse from Benzinga Newsdesk

July 28, 2023 | 12:54 pm

XOM

Exxon Mobil Corp (NYSE:XOM) reported Q2 2023 revenues of $82.91 billion, beating the consensus of $80.19 billion. However, Q2 adjusted earnings were lower than a year ago due to lower natural gas realizations and industry refining margins. The company also announced a dividend per share of $0.91 for Q3 and bought back shares worth $4.3 billion in the quarter. XOM shares are trading lower by 0.16% at $105.25 premarket.

Portfolio Pulse from Lekha Gupta

July 28, 2023 | 12:54 pm

ENPH

Enphase Energy has provided weak guidance for Q3, leading to a decrease in its share price.

Portfolio Pulse from Bill Haddad

July 28, 2023 | 12:48 pm

ROKU

Roku's shares are trading higher following the company's Q2 results, which exceeded expectations. The company also issued strong Q3 guidance.

Portfolio Pulse from Bill Haddad

July 28, 2023 | 12:48 pm

FSLR

First Solar reported strong Q2 results and announced a $1.1 billion investment in a US manufacturing facility, leading to a rise in its share prices.

Portfolio Pulse from Bill Haddad

July 28, 2023 | 12:48 pm

BZH

Beazer Homes' shares are trading higher after the company reported better-than-expected Q3 results.

Portfolio Pulse from Bill Haddad

July 28, 2023 | 12:47 pm

META

Meta Platforms, Inc. (NASDAQ:META) shares surged after reporting better-than-expected Q2 financial results. The company reported a revenue of $32 billion, up 11% YoY, beating the Street consensus estimate of $31.12 billion. Earnings per share totaled $2.98, also beating the consensus estimate of $2.91. The company saw a surge in options trading volume, with calls significantly outpacing puts. Traders expect Meta's stock to move higher.

Portfolio Pulse from Lisa Levin

July 28, 2023 | 12:46 pm

AZN

PFE

AstraZeneca's Q2 FY23 earnings beat consensus with a core EPS of $2.15, up 25% Y/Y, despite no COVID-19 vaccine sales. The strong performance of its cancer drugs offset the loss of vaccine sales. Total revenue was $11.4 billion, up 6%, beating analyst estimates. AstraZeneca's unit Alexion has agreed to buy Pfizer's preclinical gene therapy programs for up to $1 billion. The deal is expected to close in Q3.

Portfolio Pulse from Vandana Singh

July 28, 2023 | 12:46 pm

ABR

Arbor Realty Trust (NYSE:ABR) reported Q2 earnings of $0.57 per share, beating the analyst consensus estimate of $0.44 by 29.55%. This is a 9.62% increase from the same period last year. The company also reported quarterly sales of $108.54 million, beating the analyst consensus estimate of $99.11 million by 9.52%. This is a 15.15% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 28, 2023 | 12:42 pm

RRBI

Red River Bancshares (NASDAQ:RRBI) reported Q2 earnings of $1.25 per share, beating the analyst consensus estimate of $1.14 by 9.65%. However, this represents a 1.57% decrease from the same period last year.

Portfolio Pulse from Happy Mohamed

July 28, 2023 | 12:36 pm